Impact of Clostridioides difficile infection on patient-reported quality of life.

Published on Oct 7, 2021in Infection Control and Hospital Epidemiology3.254
· DOI :10.1017/ICE.2021.413
Zheyi Han5
Estimated H-index: 5
(Cleveland Clinic Lerner College of Medicine),
Brittany Lapin5
Estimated H-index: 5
(Cleveland Clinic Lerner Research Institute)
+ 2 AuthorsAbhishek Deshpande32
Estimated H-index: 32
(Cleveland Clinic Lerner College of Medicine)
Sources
Abstract
OBJECTIVE We investigated the quality of life (QoL) of patients hospitalized with C. difficile infection (CDI). DESIGN Prospective survey study. SETTING US tertiary-care referral center, acute-care setting. PARTICIPANTS Adults hospitalized with a diagnosis of CDI, defined as ≥3 episodes of unformed stool in 24 hours and a positive laboratory test for C. difficile. METHODS We surveyed patients from July 2019 to March 2020 using the disease-specific Cdiff32 questionnaire and the generic PROMIS GH survey. We compared differences in Cdiff32 scores among demographic and clinical subgroups (including CDI severity, CDI recurrence, and various comorbidities) using 2-sample t tests. We compared PROMIS GH scores to the general population T score of 50 using 1-sample t tests. We performed multivariable linear regression to identify predictors of Cdiff32 scores. RESULTS In total, 100 inpatients (mean age, 58.6 ±17.1 years; 53.0% male; 87.0% white) diagnosed with CDI completed QoL surveys. PROMIS GH physical health summary scores (T = 37.3; P < .001) and mental health summary scores (T = 43.4; P < .001) were significantly lower than those of the general population. In bivariate analysis, recurrent CDI, severe CDI, and number of stools were associated with lower Cdiff32 scores. In multivariable linear regression, recurrent CDI, severe CDI, and each additional stool in the previous 24 hours were associated with significantly decreased Cdiff32 scores. CONCLUSIONS Patients hospitalized with CDI reported low scores on the Cdiff32 and PROMIS GH, demonstrating a negative impact of CDI on QoL in multiple health domains. The Cdiff32 questionnaire is particularly sensitive to QoL changes in patients with recurrent or severe disease.
📖 Papers frequently viewed together
References22
Newest
#1Shanthini Kasturi (Tufts Medical Center)H-Index: 7
#2Jackie Szymonifka (NYU: New York University)H-Index: 36
Last. Lisa A. Mandl (Cornell University)H-Index: 35
view all 7 authors...
OBJECTIVE: To evaluate the longitudinal responsiveness (sensitivity to change) of the Patient-Reported Outcomes Measurement Information Systems (PROMIS® ) global health short form (PROMIS10) in outpatients with systemic lupus erythematosus (SLE). METHODS: SLE outpatients receiving care at an academic medical center completed PROMIS10 at two visits a minimum of one month apart. Responsiveness of PROMIS10 global physical and mental health domains was evaluated in patients with improvement or deter...
Source
#1Brittany Lapin (Cleveland Clinic)H-Index: 25
#2Sara DavinH-Index: 8
Last. Irene L. KatzanH-Index: 32
view all 5 authors...
Study Design.Retrospective cohort studyObjective.To (1) confirm validity of PROMIS physical function and pain interference computer adaptive tests (CATs) and (2) assess the validity of PROMIS Global Health (GH) and five additional PROMIS CATs: social role satisfaction, fatigue, anxiety, depression,
Source
#1Martin G. Seneviratne (Stanford University)H-Index: 8
#2Selen Bozkurt (Stanford University)H-Index: 13
Last. Tina Hernandez-Boussard (Stanford University)H-Index: 57
view all 8 authors...
BACKGROUND: The collection of patient-reported outcomes (PROs) is an emerging priority internationally, guiding clinical care, quality improvement projects and research studies. After the deployment of Patient-Reported Outcomes Measurement Information System (PROMIS) surveys in routine outpatient workflows at an academic cancer center, electronic health record data were used to evaluate survey completion rates and self-reported global health measures across 2 tumor types: breast and prostate can...
Source
#1Frédéric Barbut (Paris V: Paris Descartes University)H-Index: 37
#2Tatiana GalperineH-Index: 6
Last. Francis FagnaniH-Index: 14
view all 11 authors...
Background Clostridium difficile infection (CDI) is associated with a substantial Quality of life impact on patients that has not been so far measured with a generic validated instrument.
Source
Abstract Background A point-prevalence survey that was conducted in the United States in 2011 showed that 4% of hospitalized patients had a health care–associated infection. We repeated the survey ...
Source
#1Kirstin Heinrich (Pfizer)H-Index: 3
#2James Harnett (Pfizer)H-Index: 17
Last. Marya D. Zilberberg (UMass: University of Massachusetts Amherst)H-Index: 51
view all 6 authors...
Background Evidence of humanistic detriments of Clostridium difficile infection (CDI) remains limited.
Source
Objectives Dysfunction after transient ischaemic attack (TIA) and minor stroke is often underestimated by clinical measures. Patient-reported outcome measures used in value-based healthcare may help in detecting these problems. The Patient-Reported Outcomes Measurement Information System 10-Question Short Form (PROMIS-10 Global Health) is a concise patient-centred outcome measuring tool proposed for assessing health status in patients who had stroke. This study aims to address the validity of th...
Source
#1L. Clifford McDonald (CDC: Centers for Disease Control and Prevention)H-Index: 71
#2Dale N. Gerding (VA: United States Department of Veterans Affairs)H-Index: 105
Last. Mark H. Wilcox (Leeds Teaching Hospitals NHS Trust)H-Index: 104
view all 14 authors...
A panel of experts was convened by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) to update the 2010 clinical practice guideline on Clostridium difficile infection (CDI) in adults. The update, which has incorporated recommendations for children (following the adult recommendations for epidemiology, diagnosis, and treatment), includes significant changes in the management of this infection and reflects the evolving controversy over best...
Source
#1Bronwen E. Shaw (Center for International Blood and Marrow Transplant Research)H-Index: 44
#2Karen L. SyrjalaH-Index: 58
Last. Stephanie J. LeeH-Index: 106
view all 11 authors...
BACKGROUND Patient-reported outcomes for hematopoietic cell transplantation (HCT) survivors are well characterized with established measures; however, there is little experience with the new, freely available Patient-Reported Outcomes Measurement Information System (PROMIS) measures in this population. The aim of this study was to compare the performance of the PROMIS measures in the HCT setting with the performance of the commonly used 36-Item Short Form Health Survey (SF-36). METHODS Adult HCT...
Source
#1Irene L. Katzan (Cleveland Clinic)H-Index: 32
#2Brittany Lapin (Cleveland Clinic)H-Index: 25
Background and Purpose— The International Consortium for Health Outcomes Measurement recently included the 10-item PROMIS GH (Patient-Reported Outcomes Measurement Information System Global Health) scale as part of their recommended Standard Set of Stroke Outcome Measures. Before collection of PROMIS GH is broadly implemented, it is necessary to assess its performance in the stroke population. The objective of this study was to evaluate the psychometric properties of PROMIS GH in patients with i...
Source
Cited By0
Newest
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.